|
Market Closed -
Nasdaq
16:00:00 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 514.65 USD | +2.53% |
|
+6.07% | +13.52% |
| 10-15 | Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $654 From $653 | MT |
| 10-09 | Vertex Pharmaceuticals Says Alyftrek Delivers Pancreatic Function Recovery in Some Children | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.53% | +6.07% | +1.24% | +7.11% | +13.52% | +22.80% | +42.22% | +177.45% | +520.66% | 130B | |
| +3.49% | +10.04% | +11.34% | +11.92% | +19.45% | +58.68% | +119.56% | +426.69% | +1,530.25% | 1,144B | |
| +2.19% | +4.32% | -3.94% | +4.24% | +25.32% | +33.88% | +69.52% | +58.36% | +125.79% | 625B | |
| +2.26% | +5.37% | +9.52% | +14.09% | +26.52% | +24.57% | +97.69% | +166.65% | +368.07% | 511B | |
| -0.54% | +4.50% | +6.25% | +16.12% | +18.10% | +38.03% | +63.17% | +8.33% | +66.85% | 377B | |
| +3.25% | +4.45% | +0.97% | +19.21% | +40.89% | +71.80% | +44.44% | +82.93% | +139.50% | 366B | |
| -0.25% | +2.80% | +8.58% | +0.45% | +15.05% | +20.60% | +49.23% | +62.60% | +68.36% | 291B | |
| -0.26% | +2.41% | +0.29% | +0.83% | -8.66% | +0.98% | +24.71% | +42.12% | +154.36% | 262B | |
| +3.29% | +6.32% | +13.82% | +20.53% | +34.11% | +44.71% | +57.43% | +109.36% | +171.79% | 237B | |
| +2.25% | +5.81% | +4.26% | +17.49% | +27.51% | +27.13% | +101.17% | +134.09% | +110.62% | 194B | |
| -0.62% | +1.64% | +0.06% | -19.72% | -20.02% | -26.71% | -61.87% | -22.10% | +83.46% | 174B | |
| +2.28% | +6.13% | +8.86% | +21.66% | +20.92% | +21.95% | -1.76% | -29.65% | -7.47% | 172B | |
| +4.84% | +8.84% | -2.19% | +2.53% | +14.35% | +41.50% | +9.25% | +6.22% | +22.48% | 126B | |
| +1.95% | +7.09% | +17.78% | +23.89% | +25.58% | +30.76% | +127.49% | +399.84% | +536.07% | 120B | |
| -0.31% | +2.64% | -2.46% | -1.53% | +2.16% | +13.28% | +27.46% | +5.70% | -10.09% | 100B | |
| -0.46% | +1.98% | -1.81% | -4.57% | -11.46% | -15.12% | -25.50% | -12.76% | +5.84% | 99.04B | |
| +6.69% | +11.94% | +57.15% | +306.93% | +720.89% | +788.69% | +201.09% | -27.31% | - | 96.65B | |
| +3.25% | +7.22% | +2.88% | +20.13% | +4.61% | +40.00% | -0.12% | +43.50% | +117.51% | 80.63B | |
| -0.26% | +2.89% | +10.11% | +8.75% | +19.09% | +27.18% | +0.79% | -28.22% | +47.83% | 71.51B | |
| +1.26% | +7.80% | -2.09% | -11.98% | -21.01% | -9.04% | +44.08% | +67.94% | +449.45% | 66.89B | |
| Average | +1.02% | +5.36% | +7.03% | +22.90% | +48.35% | +62.78% | +49.50% | +83.59% | +236.91% | 262.23B | |
| Weighted average by Cap. | +0.83% | +4.99% | +6.53% | +15.28% | +31.43% | +48.67% | +68.25% | +150.69% | +467.62% |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
